首頁 > 市場調查報告書 > 製藥

骨疾病

市場調查報告書

商品編碼

1629613

骨形成蛋白市場：按類型、按應用、按最終用戶、按地區

Bone Morphogenetic Protein Market, By Type (Recombinant Bone Morphogenetic Proteins, Synthetic Bone Morphogenetic Proteins, and Natural Bone Morphogenetic Proteins), By Application, By End User, By Geography

出版日期: 2024年12月04日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

估計2024年全球骨形成蛋白市場規模為3.423億美元，預計2031年將達4.445億美元，2024年至2031年年複合成長率為3.8%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	3.423億美元
實際資料	2019-2023	預測期	2024-2031
預測2024-2031年年複合成長率：	3.80%	2031年價值預測	4.445億美元

圖：2024年各地區骨形成蛋白市場佔有率（%）

由於整形外科疾病的流行和脊椎融合手術數量的增加，過去幾年骨形成蛋白的全球市場出現了顯著成長。骨形成蛋白（BMP）屬於轉化生長因子-B（TGF-B）超家族。 BMP 在骨形成、控制成骨細胞分化和基材礦化中發揮重要作用。 BMP 被核准用於脊椎融合手術和長骨骨折的癒合。調查 BMP 功效和安全性的各種臨床和臨床前研究已證明其誘導新骨形成的潛力。隨著人們對骨形成蛋白的好處和這些新型生技藥品的商業可用性的認知不斷提高，骨形成蛋白市場預計將在預測期內出現顯著成長。

市場動態：

全球骨骨形成蛋白骨形成蛋白市場的主要成長動力是老年人口的增加以及相關的整形外科手術和疾病的增加、脊椎疾病盛行率的增加、替代治療方法的缺乏，其中包括商業性可用性和採用。然而，使用 BMP 的安全問題和高成本的缺點預計將限制市場成長。持續的研發重點是開發更安全、更便宜的BMP 配方，預計在未來幾年為市場相關人員創造有利的機會。

本研究的主要特點

本報告詳細分析了全球骨形成蛋白市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

闡明各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球骨形成蛋白市場的主要企業。

本研究涵蓋的主要企業包括 Medtronic、Stryker、DePuy Synthes、NuVasive、Orthofix Holdings、Smith & Nephew、Thermo Fisher Scientific、R&D Systems、Ember Therapeutics、Sigma Aldrich、Cellumed Co. Ltd.、ProSpec 和 Wright Medical Group。和Bioventus。

本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

骨形成蛋白的全球市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。

透過用於分析全球骨形成蛋白市場的各種策略矩陣，將促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 342.3 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	3.80%	2031 Value Projection:	US$ 444.5 Mn

Global bone morphogenetic protein market has been witnessing notable growth in the past few years, owing to increasing prevalence of orthopedic diseases and rising number of spinal fusion surgeries. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-B (TGF-B) superfamily. BMPs play an important role in bone formation and regulate osteoblast differentiation and matrix mineralization. They have been approved for use in spinal fusion and long bone fracture healing. Various clinical and preclinical studies investigating their effectiveness and safety have demonstrated their potential to induce new bone formation. With rising awareness regarding their benefits and commercial availability of these novel biologics, the bone morphogenetic protein market is expected to experience significant growth over the forecast period.

Market Dynamics:

The primary growth drivers for the global bone morphogenetic protein market include rising geriatric population and subsequent increase in orthopedic surgeries and diseases, increasing prevalence of spinal disorders, lack of alternative treatment options, and commercial availability and adoption of bone morphogenetic proteins. However, shortcomings related to safety concerns over BMP use and high costs are expected to restrain the market growth. Ongoing research and development activities focusing on developing safer and affordable BMP formulations is expected to create lucrative opportunities for market players over the next few years.

Key Features of the Study:

This report provides in-depth analysis of the global bone morphogenetic protein market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bone morphogenetic protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Stryker, DePuy Synthes, NuVasive, Orthofix Holdings, Smith & Nephew, Thermo Fisher Scientific, R&D Systems, Ember Therapeutics, Sigma Aldrich Co., Cellumed Co. Ltd., ProSpec, Wright Medical Group N.V., Amedica Corporation, and Bioventus

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global bone morphogenetic protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone morphogenetic protein market

Market Segmentation

By Type Insights (Revenue, USD Mn, 2019 - 2031)
- Recombinant Bone Morphogenetic Proteins (rhBMPs)
- Synthetic Bone Morphogenetic Proteins
- Natural Bone Morphogenetic Proteins
By Application Insights (Revenue, USD Mn, 2019 - 2031)
- Orthopedic Surgeries
- Dental Surgeries
- Spinal Surgeries
- Craniofacial Surgeries
- Other Applications
By End User Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Research Institutions
- Others
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic
- Stryker
- DePuy Synthes
- NuVasive
- Orthofix Holdings
- Smith & Nephew
- Thermo Fisher Scientific
- R&D Systems
- Ember Therapeutics
- Sigma Aldrich Co.
- Cellumed Co. Ltd.
- ProSpec
- Wright Medical Group N.V.
- Amedica Corporation
- Bioventus

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Bone Morphogenetic Protein Market, By Type
- Global Bone Morphogenetic Protein Market, By Application
- Global Bone Morphogenetic Protein Market, By End User
- Global Bone Morphogenetic Protein Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Bone Morphogenetic Protein Market, By Type, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Recombinant Bone Morphogenetic Proteins (rhBMPs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Synthetic Bone Morphogenetic Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Natural Bone Morphogenetic Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Bone Morphogenetic Protein Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Orthopedic Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Dental Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Spinal Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Craniofacial Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Bone Morphogenetic Protein Market, By End User, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Bone Morphogenetic Protein Market, By Region, 2019 - 2031, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DePuy Synthes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NuVasive
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orthofix Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Smith & Nephew
Thermo Fisher Scientific
R&D Systems
Ember Therapeutics
Sigma Aldrich Co.
Cellumed Co. Ltd.
ProSpec
Wright Medical Group N.V.
Amedica Corporation
Bioventus